MedPath
FDA Approval

Naftifine hydrochloride

January 15, 2021

HUMAN PRESCRIPTION DRUG LABEL

Naftifine(20 mg in 1 g)

Registrants (1)

Xiromed Pharma España, S.L.

468835741

Products (1)

Naftifine hydrochloride

70700-161

ANDA210038

ANDA (C73584)

TOPICAL

January 15, 2021

NaftifineActive
Code: 25UR9N9041Class: ACTIBQuantity: 20 mg in 1 g
CETYL ESTERS WAXInactive
Code: D072FFP9GUClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCNClass: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
SORBITAN MONOSTEARATEInactive
Code: NVZ4I0H58XClass: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1YClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath